PUBLISHER: IMARC | PRODUCT CODE: 1519777
PUBLISHER: IMARC | PRODUCT CODE: 1519777
The global histology and cytology market size reached US$ 16.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.92% during 2024-2032.
Histology and cytology are branches of biology dealing with chemistry, structure and function of tissues and cells of animals and plants at a microscopic level. They assist medical staff in diagnosing diseases, such as cancer, cervical disease, tuberculosis, human papilloma virus (HPV) infection, abnormal growth, inflammatory diseases, leukemia, smallpox, and rabies. They also help enhance the sensitivity, specificity and accuracy of diagnostic methods. As a result, they find extensive applications in hospitals, clinics, and research and development (R&D) institutes across the globe.
At present, there is a rise in the number of cancer patients across the globe. This, along with the favorable reimbursement policies for laboratory tests, represents one of the key factors driving the market. Moreover, the growing integration of digital solutions in cytological diagnosis aids in rapidly interpreting primary diagnostic data, which is positively influencing the market. In addition, major manufacturers are launching new and advanced cytology systems for helping in the rapid on-site evaluation of cytology samples. This, coupled with the rising traction of immunohistochemistry (IHC) for visualizing cellular components, is propelling the growth of the market. Besides this, there is an increase in the standardization of pathological laboratories around the world. This, along with technological advancements in diagnostic and molecular techniques, is contributing to the growth of the market. Additionally, increasing awareness about the advanced therapeutics and enhanced healthcare infrastructure worldwide is offering lucrative growth opportunities to industry investors. Furthermore, key market players are focusing on acquisitions, mergers, partnerships, and collaborations to expand their customer base. They are also launching new products and receiving product approvals from regulatory authorities, which is projected to bolster the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global histology and cytology market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, type of examination, test type and application.
Instruments and Analysis Software System
Consumable and Reagents
Histology
Cytology
Microscopy Tests
Molecular Genetics Tests
Flow Cytometry
Drug Discovery and Designing
Clinical Diagnostics
Point-of-Care (PoC)
Non-Point-of-Care
Research
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Carl Zeiss AG, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Koninklijke Philips N.V., Merck KGaA, Olympus Corporation, PerkinElmer Inc., Sysmex Corporation, Thermo Fisher Scientific Inc. and Trivitron Healthcare.